NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.97
+0.45 (1.27%)
At close: Dec 4, 2025, 4:00 PM EST
35.85
-0.12 (-0.33%)
After-hours: Dec 4, 2025, 5:41 PM EST
NAMS Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$45.80
Upside
+27.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +2.86% | Dec 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +22.32% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $40 → $46 | Strong Buy | Maintains | $40 → $46 | +27.88% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +44.56% | Oct 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $42 → $50 | Strong Buy | Maintains | $42 → $50 | +39.00% | Oct 17, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $45 | Buy | Initiates | $45 | +25.10% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +8.42% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | -24.94% | Jul 17, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +16.76% | Jun 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +11.20% | Jun 12, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +22.32% | Jun 10, 2025 |
| Needham | Needham | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +11.20% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +16.76% | Apr 8, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +44.56% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Maintains $46 → $42 | Strong Buy | Maintains | $46 → $42 | +16.76% | Feb 27, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +11.20% | Jan 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.